Big Pharma losing price leverage amid squeeze by payers
Latest quarterly results raise pressure on drugmakers to pump up sales volumes, find lucrative new treatments
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
BEING a big drug company isn't what it used to be.
The largest drugmakers are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That's raising the pressure to pump up sales volumes and find lucrative new treatments for niche markets.
Share with us your feedback on BT's products and services
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
